|
|
Ulrike Protzer，慕尼黑工业大学，德国
Lucifora, J. and U. Protzer (2016). "Attacking hepatitis B virus cccDNA - The holy grail to hepatitis B cure." J Hepatol 64(1 Suppl): S41-8.
Meredith, L. W. and K. Hu, et al. (2016). "Lentiviral hepatitis B pseudotype entry requires sodium taurocholate co-transporting polypeptide and additional hepatocyte-specific factors." J Gen Virol 97(1): 121-7.
Sautto, G. A. and K. Wisskirchen, et al. (2016). "Chimeric antigen receptor (CAR)-engineered T cells redirected against hepatitis C virus (HCV) E2 glycoprotein." Gut 65(3): 512-23.
Ringelhan, M. and U. Protzer (2015). "Oncogenic potential of hepatitis B virus encoded proteins." Curr Opin Virol 14: 109-15.
Protzer, U. (2015). "Hepatitis: Epigenetic control of HBV by HBx protein--releasing the break?" Nat Rev Gastroenterol Hepatol 12(10): 558-9.
Hoh, A. and M. Heeg, et al. (2015). "Hepatitis B Virus-Infected HepG2hNTCP Cells Serve as a Novel Immunological Tool To Analyze the Antiviral Efficacy of CD8+ T Cells In Vitro." J Virol 89(14): 7433-8.
Dembek, C. and U. Protzer (2015). "Mouse models for therapeutic vaccination against hepatitis B virus." Med Microbiol Immunol 204(1): 95-102.
Protzer, U. and F. Bohm, et al. (2015). "Molecular detection of hepatitis E virus (HEV) in liver biopsies after liver transplantation." Mod Pathol 28(4): 523-32.
Lucifora, J. and Y. Xia, et al. (2014). "[Specific degradation of nuclear hepatitis B virus covalently closed circular DNA]." Med Sci (Paris) 30(8-9): 724-6.
Xia, Y. and J. Lucifora, et al. (2014). "Virology. Response to Comment on "Specific and nonhepatotoxic degradation of nuclear hepatitis B virus cccDNA"." Science 344(6189): 1237.
Lucifora, J. and Y. Xia, et al. (2014). "Specific and nonhepatotoxic degradation of nuclear hepatitis B virus cccDNA." Science 343(6176): 1221-8.
Hosel, M. and J. Lucifora, et al. (2014). "Hepatitis B virus infection enhances susceptibility toward adeno-associated viral vector transduction in vitro and in vivo." Hepatology 59(6): 2110-20.
Golsaz, S. F. and H. Mohammadi, et al. (2014). "Monoclonal antibodies to various epitopes of hepatitis B surface antigen inhibit hepatitis B virus infection." J Gastroenterol Hepatol 29(5): 1083-91.
Sprinzl, M. F. and C. Russo, et al. (2014). "Hepatitis B virus-specific T-cell responses during IFN administration in a small cohort of chronic hepatitis B patients under nucleos(t)ide analogue treatment." J Viral Hepat 21(9): 633-41.
Krebs, K. and N. Bottinger, et al. (2013). "T cells expressing a chimeric antigen receptor that binds hepatitis B virus envelope proteins control virus replication in mice." Gastroenterology 145(2): 456-65.
Benhenda, S. and A. Ducroux, et al. (2013). "Methyltransferase PRMT1 is a binding partner of HBx and a negative regulator of hepatitis B virus transcription." J Virol 87(8): 4360-71.
Lucifora, J. and K. Esser, et al. (2013). "Ezetimibe blocks hepatitis B virus infection after virus uptake into hepatocytes." Antiviral Res 97(2): 195-7.
Buchmann, P. and C. Dembek, et al. (2013). "A novel therapeutic hepatitis B vaccine induces cellular and humoral immune responses and breaks tolerance in hepatitis B virus (HBV) transgenic mice." Vaccine 31(8): 1197-203.
Ringelhan, M. and M. Heikenwalder, et al. (2013). "Direct effects of hepatitis B virus-encoded proteins and chronic infection in liver cancer development." Dig Dis 31(1): 138-51.
Stross, L. and J. Gunther, et al. (2012). "Foxp3+ regulatory T cells protect the liver from immune damage and compromise virus control during acute experimental hepatitis B virus infection in mice." Hepatology 56(3): 873-83.
Kutscher, S. and T. Bauer, et al. (2012). "Design of therapeutic vaccines: hepatitis B as an example." Microb Biotechnol 5(2): 270-82.
Vincent, I. E. and C. Zannetti, et al. (2011). "Hepatitis B virus impairs TLR9 expression and function in plasmacytoid dendritic cells." PLoS One 6(10): e26315.
Bauer, T. and M. Sprinzl, et al. (2011). "Immune control of hepatitis B virus." Dig Dis 29(4): 423-33.
Cornberg, M. and U. Protzer, et al. (2011). "[Prophylaxis, diagnosis and therapy of hepatitis B virus infection - the German guideline]." Z Gastroenterol 49(7): 871-930.
Ebert, G. and H. Poeck, et al. (2011). "5' Triphosphorylated small interfering RNAs control replication of hepatitis B virus and induce an interferon response in human liver cells and mice." Gastroenterology 141(2): 696-706, 706.e1-3.
Lucifora, J. and S. Arzberger, et al. (2011). "Hepatitis B virus X protein is essential to initiate and maintain virus replication after infection." J Hepatol 55(5): 996-1003.
von Freyend, M. J. and A. Untergasser, et al. (2011). "Sequential control of hepatitis B virus in a mouse model of acute, self-resolving hepatitis B." J Viral Hepat 18(3): 216-26.
Lucifora, J. and I. E. Vincent, et al. (2010). "Hepatitis B virus replication in primary macaque hepatocytes: crossing the species barrier toward a new small primate model." Hepatology 51(6): 1954-60.
Sarrazin, C. and T. Berg, et al. (2010). "[Prophylaxis, diagnosis and therapy of hepatitis C virus (HCV) infection: the German guidelines on the management of HCV infection]." Z Gastroenterol 48(2): 289-351.
Protzer, U. and H. Abken (2010). "Can engineered "designer" T cells outsmart chronic hepatitis B?" Hepat Res Treat 2010: 901216.
Arzberger, S. and M. Hosel, et al. (2010). "Apoptosis of hepatitis B virus-infected hepatocytes prevents release of infectious virus." J Virol 84(22): 11994-2001.
Quasdorff, M. and U. Protzer (2010). "Control of hepatitis B virus at the level of transcription." J Viral Hepat 17(8): 527-36.
Hosel, M. and M. Quasdorff, et al. (2009). "Not interferon, but interleukin-6 controls early gene expression in hepatitis B virus infection." Hepatology 50(6): 1773-82.
Op, D. B. M. and R. S. Binda, et al. (2009). "Hepatitis B virus surface antigen impairs myeloid dendritic cell function: a possible immune escape mechanism of hepatitis B virus." Immunology 126(2): 280-9.
Cornberg, M. and U. Protzer, et al. (2008). "The German guideline for the management of hepatitis B virus infection: short version." J Viral Hepat 15 Suppl 1: 1-21.
Jenke, A. C. and A. D. Wilhelm, et al. (2008). "Long-term suppression of hepatitis B virus replication by short hairpin RNA expression using the scaffold/matrix attachment region-based replicating vector system pEPI-1." Antimicrob Agents Chemother 52(7): 2355-9.
Quasdorff, M. and M. Hosel, et al. (2008). "A concerted action of HNF4alpha and HNF1alpha links hepatitis B virus replication to hepatocyte differentiation." Cell Microbiol 10(7): 1478-90.
Bohne, F. and M. Chmielewski, et al. (2008). "T cells redirected against hepatitis B virus surface proteins eliminate infected hepatocytes." Gastroenterology 134(1): 239-47.
Cornberg, M. and U. Protzer, et al. (2007). "Prophylaxis, diagnosis and therapy of hepatitis B virus (HBV) infection: the German guidelines for the management of HBV infection." Z Gastroenterol 45(12): 1281-328.
Bohne, F. and U. Protzer (2007). "Adoptive T-cell therapy as a therapeutic option for chronic hepatitis B." J Viral Hepat 14 Suppl 1: 45-50.
Protzer, U. and S. Seyfried, et al. (2007). "Antiviral activity and hepatoprotection by heme oxygenase-1 in hepatitis B virus infection." Gastroenterology 133(4): 1156-65.
Wedemeyer, H. and M. Cornberg, et al. (2007). "[German guidelines on diagnosis and therapy of hepatitis B]." Dtsch Med Wochenschr 132(34-35): 1775-82.
Jost, S. and P. Turelli, et al. (2007). "Induction of antiviral cytidine deaminases does not explain the inhibition of hepatitis B virus replication by interferons." J Virol 81(19): 10588-96.
Cornberg, M. and U. Protzer, et al. (2007). "[Prophylaxis, Diagnosis and Therapy of Hepatitis-B-Virus-(HBV-)Infection: upgrade of the guideline, AWMF-Register 021/011]." Z Gastroenterol 45(6): 525-74.
Untergasser, A. and U. Zedler, et al. (2006). "Dendritic cells take up viral antigens but do not support the early steps of hepatitis B virus infection." Hepatology 43(3): 539-47.
Siebler, J. and U. Protzer, et al. (2006). "Overexpression of STAT-1 by adenoviral gene transfer does not inhibit hepatitis B virus replication." Eur J Gastroenterol Hepatol 18(2): 167-74.
Shin, E. C. and U. Protzer, et al. (2005). "Liver-directed gamma interferon gene delivery in chronic hepatitis C." J Virol 79(21): 13412-20.
Isogawa, M. and K. Kakimi, et al. (2005). "Differential dynamics of the peripheral and intrahepatic cytotoxic T lymphocyte response to hepatitis B surface antigen." Virology 333(2): 293-300.
Dumortier, J. and K. Schonig, et al. (2005). "Liver-specific expression of interferon gamma following adenoviral gene transfer controls hepatitis B virus replication in mice." Gene Ther 12(8): 668-77.
Untergasser, A. and U. Protzer (2004). "Hepatitis B virus-based vectors allow the elimination of viral gene expression and the insertion of foreign promoters." Hum Gene Ther 15(2): 203-10.
Sprinzl, M. and J. Dumortier, et al. (2004). "Construction of recombinant adenoviruses that produce infectious hepatitis B virus." Methods Mol Med 96: 209-18.
Schulze-Bergkamen, H. and A. Untergasser, et al. (2003). "Primary human hepatocytes--a valuable tool for investigation of apoptosis and hepatitis B virus infection." J Hepatol 38(6): 736-44.
Li, Y. and H. Hacker, et al. (2002). "Woodchuck hepatitis virus replication and antigen expression gradually decrease in preneoplastic hepatocellular lineages." J Hepatol 37(4): 478-85.
Sprinzl, M. F. and H. Oberwinkler, et al. (2001). "Transfer of hepatitis B virus genome by adenovirus vectors into cultured cells and mice: crossing the species barrier." J Virol 75(11): 5108-18.
Radecke, K. and U. Protzer, et al. (2000). "Selection of hepatitis B virus variants with aminoacid substitutions inside the core antigen during interferon-alpha therapy." J Med Virol 62(4): 479-86.
Protzer, U. and H. Schaller (2000). "Immune escape by hepatitis B viruses." Virus Genes 21(1-2): 27-37.
Protzer, U. and M. Nassal, et al. (1999). "Interferon gene transfer by a hepatitis B virus vector efficiently suppresses wild-type virus infection." Proc Natl Acad Sci U S A 96(19): 10818-23.
Hohler, T. and G. Gerken, et al. (1997). "HLA-DRB1*1301 and *1302 protect against chronic hepatitis B." J Hepatol 26(3): 503-7.
Protzer, U. and H. P. Dienes, et al. (1996). "Post-infantile giant cell hepatitis in patients with primary sclerosing cholangitis and autoimmune hepatitis." Liver 16(4): 274-82.
Protzer, U. and B. Goergen, et al. (1996). "Pre-core mutants of hepatitis B virus in patients receiving immunosuppressive treatment after orthotopic liver transplantation." J Med Virol 50(2): 135-44.
Protzer, U. and M. Trippler, et al. (1996). "Rare pre-core stop-codon mutant nt. 1897 predominates over wide-spread mutant nt. 1896 in an unusual course of chronic hepatitis B." J Viral Hepat 3(3): 155-62.
Protzer, U. and F. R. Ochsendorf, et al. (1993). "Exacerbation of lichen planus during interferon alfa-2a therapy for chronic active hepatitis C." Gastroenterology 104(3): 903-5. |
|
发表于 2016-5-10 01:54:21
